Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.4184
+0.0312 (8.06%)
At close: Nov 13, 2026, 4:00 PM EST
0.4252
+0.0068 (1.63%)
After-hours: Nov 13, 2026, 7:47 PM EST
Ensysce Biosciences Revenue
Ensysce Biosciences had revenue of $2.18M in the quarter ending September 30, 2026, with 342.43% growth. This brings the company's total for the last twelve months to $6.19M, up 37.91% year-over-year. In the year 2025, Ensysce Biosciences had annual revenue of $5.07M, down -2.75%. That makes Ensysce Biosciences the 39,297th largest company in the world by revenue and 5,192nd in the United States.
Revenue (ttm)
$6.19M
Revenue Growth
+37.91%
P/S Ratio
1.32
Revenue / Employee
$618,928
Employees
10
Market Cap
8.14M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.07M | -143.38K | -2.75% |
| Dec 31, 2024 | 5.21M | 2.98M | 133.58% |
| Dec 31, 2023 | 2.23M | -292.86K | -11.61% |
| Dec 31, 2022 | 2.52M | -1.01M | -28.54% |
| Dec 31, 2021 | 3.53M | -400.01K | -10.18% |
| Dec 31, 2020 | 3.93M | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Immuron | 5.34M |
| Vistagen Therapeutics | 2.50M |
| Longeveron | 1.17M |
| Kiora Pharmaceuticals | 1.00M |
| Addex Therapeutics | 102.81K |
| Soligenix | 2.34K |
ENSC News
- 3 days ago - Ensysce Biosciences Earnings release: Q3 2026 - Filings
- 3 days ago - Ensysce Biosciences Quarterly report: Q3 2026 - Filings
- 3 days ago - Ensysce Biosciences Proxy statement: Proxy filing - Filings
- 3 days ago - Ensysce Biosciences initiated with a Buy at UBS - TheFly
- 16 days ago - Ensysce Biosciences Proxy statement: Proxy filing - Filings
- 23 days ago - Ensysce Biosciences registers to sell 433.91M shares of common stock for holders - TheFly
- 23 days ago - Ensysce Biosciences Registration statement: Registration filing - Filings
- 25 days ago - Ensysce Biosciences participates in Family Office Summit, Dubai - TheFly